News | September 12, 2025
Briefs: Torrent Pharmaceuticals and Hemant Surgical Industries
Hemant Surgical Industries receives order
Hemant Surgical Industries receives order
Funding to support Phase 2b trial with MRM Health’s lead program MH002 in ulcerative colitis and advance two additional programs to IND approval
Argo will receive an upfront payment of $160 million, an option for Profit & Loss split across multiple geographies and potential near-term equity
This acquisition expands HGM's healthcare platform capabilities in revenue cycle management
Projects 5X revenue growth by 2028, accelerates global market leadership and paves the way for IPO
Dr. Venkatraman brings over 25 years of experience in small molecule and Biologics drug development, manufacturing, and advancing strategic growth initiatives
Revenue from operations rose 14.8 per cent year-on-year to Rs. 3,942 crore
NewCo’s pipeline includes five investigational medicines
The company has made an investment of Rs. 565.40 crore in DRL Russia for a total equity stake of 45.19%
Net profit doubled to Rs. 10.8 crore, with PAT margin expanding by 560 bps to 14.3%, reflecting strong operational execution
Subscribe To Our Newsletter & Stay Updated
